207560749	207560749	CD	B-NP	O
|	|	NN	I-NP	O
NTH	NTH	NN	I-NP	O
|	|	NN	I-NP	O
46499404	46499404	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
0823120	0823120	CD	B-NP	O
|	|	CC	I-NP	O
9/18/2003	9/18/2003	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CONGESTIVE	CONGESTIVE	NNP	I-NP	I-protein
HEART	HEART	NNP	I-NP	I-protein
FAILURE	FAILURE	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/2/2003	5/2/2003	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/18/2003	1/18/2003	CD	B-NP	O
CHIEF	CHIEF	NN	I-NP	O
COMPLAINT	COMPLAINT	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
72-year-old	72-year-old	JJ	I-NP	O
man	man	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
significant	significant	JJ	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	B-protein
post	post	NN	I-NP	I-protein
CABG	CABG	NN	I-NP	I-protein
x	x	SYM	B-NP	I-protein
2	2	CD	B-NP	I-protein
,	,	,	O	O
stents	stent	NNS	B-NP	O
and	and	CC	O	O
brachytherapy	brachytherapy	NN	B-NP	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
NSVT	NSVT	NN	I-NP	O
leading	lead	VBG	B-VP	O
to	to	TO	B-PP	O
fatigue	fatigue	NN	B-NP	O
and	and	CC	I-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
symptoms	symptom	NNS	I-NP	O
first	first	RB	B-ADVP	O
developed	develop	VBD	B-VP	O
last	last	JJ	B-NP	O
September	September	NNP	I-NP	O
,	,	,	O	O
2002	2002	CD	B-NP	O
when	when	WRB	B-ADVP	O
he	he	PRP	B-NP	O
noticed	notice	VBD	B-VP	O
fatigue	fatigue	NN	B-NP	O
and	and	CC	I-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
recently	recently	RB	I-VP	O
developed	develop	VBN	I-VP	O
bacteremia	bacteremia	NN	B-NP	O
after	after	IN	B-PP	O
a	a	DT	B-NP	O
colonoscopy	colonoscopy	NN	I-NP	O
and	and	CC	O	O
never	never	RB	B-VP	O
felt	feel	VBD	I-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
quite	quite	RB	I-VP	O
recovered	recover	VBN	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
being	be	VBG	I-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
atenolol	atenolol	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
for	for	IN	B-PP	O
his	his	PRP$	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
wife	wife	NN	I-NP	O
and	and	CC	I-NP	O
son	son	NN	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
are	be	VBP	B-VP	O
a	a	DT	B-NP	O
nurse	nurse	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
PA	PA	NN	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
,	,	,	O	O
felt	feel	VBD	B-VP	O
his	his	PRP$	B-NP	O
pulse	pulse	NN	I-NP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
frequently	frequently	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
30s	30	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
was	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
occasionally	occasionally	RB	B-ADJP	O
normal	normal	JJ	I-ADJP	O
.	.	.	O	O

He	He	PRP	B-NP	O
decreased	decrease	VBD	B-VP	O
his	his	PRP$	B-NP	O
atenolol	atenolol	NN	I-NP	O
to	to	TO	B-PP	O
25	25	CD	B-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
but	but	CC	O	O
his	his	PRP$	B-NP	O
symptoms	symptom	NNS	I-NP	O
persisted	persist	VBD	B-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
and	and	CC	O	O
found	find	VBN	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
frequent	frequent	JJ	B-NP	O
PVCs	PVC	NNS	I-NP	O
on	on	IN	B-PP	O
EKG	EKG	NN	B-NP	B-protein
.	.	.	O	O

Over	Over	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
few	few	JJ	I-NP	O
months	month	NNS	I-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
also	also	RB	I-VP	O
noticed	notice	VBN	I-VP	O
increased	increase	VBN	B-NP	O
angina	angina	NN	I-NP	O
,	,	,	O	O
both	both	CC	O	O
with	with	IN	B-PP	O
and	and	CC	I-PP	O
without	without	IN	I-PP	O
activity	activity	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBD	I-VP	O
increased	increase	VBN	I-VP	O
difficulty	difficulty	NN	B-NP	O
walking	walk	VBG	B-VP	O
up	up	RP	B-PRT	O
the	the	DT	B-NP	O
stairs	stair	NNS	I-NP	O
causing	cause	VBG	B-VP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
relieved	relieve	VBN	I-VP	O
by	by	IN	B-PP	O
sublingual	sublingual	JJ	B-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
.	.	.	O	O

Then	Then	RB	O	O
two	two	CD	B-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-VP	O
admission	admission	VB	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
noticed	notice	VBD	B-VP	O
pain	pain	NN	B-NP	O
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
but	but	CC	O	O
was	be	VBD	B-VP	O
again	again	RB	I-VP	O
relieved	relieve	VBN	I-VP	O
by	by	IN	B-PP	O
sublingual	sublingual	JJ	B-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
he	he	PRP	B-NP	O
felt	feel	VBD	B-VP	O
chest	chest	NN	B-NP	O
heaviness	heaviness	NN	I-NP	O
that	that	WDT	B-NP	O
woke	wake	VBD	B-VP	O
him	him	PRP	B-NP	O
up	up	RP	B-PRT	O
from	from	IN	B-PP	O
sleep	sleep	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
take	take	VB	I-VP	O
any	any	DT	B-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
but	but	CC	O	O
his	his	PRP$	B-NP	O
wife	wife	NN	I-NP	O
told	tell	VBD	B-VP	O
him	him	PRP	B-NP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
``	``	``	O	O
gasping	gasp	VBG	B-VP	O
for	for	IN	B-PP	O
breath	breath	NN	B-NP	O
''	''	''	O	O
.	.	.	O	O

Over	Over	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
month	month	NN	I-NP	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
seeing	see	VBG	I-VP	O
his	his	PRP$	B-NP	O
cardiologist	cardiologist	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Verdun	Verdun	NNP	I-NP	O
.	.	.	O	O

Because	Because	IN	B-PP	O
of	of	IN	I-PP	O
his	his	PRP$	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
for	for	IN	B-PP	O
3-4	3-4	CD	B-NP	O
days	day	NNS	I-NP	O
but	but	CC	O	O
this	this	DT	B-NP	O
also	also	RB	B-ADVP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
relieve	relieve	VB	I-VP	O
his	his	PRP$	B-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
Holter	Holter	NNP	B-NP	O
monitoring	monitor	VBG	B-VP	O
with	with	IN	B-PP	O
exercise	exercise	NN	B-NP	O
,	,	,	O	O
going	go	VBG	B-VP	O
up	up	IN	B-PP	O
and	and	CC	I-PP	O
down	down	IN	I-PP	O
the	the	DT	B-NP	O
stairs	stair	NNS	I-NP	O
,	,	,	O	O
at	at	IN	B-PP	O
clinic	clinic	NN	B-NP	O
and	and	CC	O	O
this	this	DT	B-NP	O
also	also	RB	B-ADVP	O
showed	show	VBD	B-VP	O
frequent	frequent	JJ	B-NP	O
PVCs	PVC	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
electrocardiogram	electrocardiogram	NN	I-NP	O
that	that	WDT	B-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
30	30	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
bypass	bypass	IN	B-PP	O
graft	graft	NN	B-NP	O
in	in	IN	B-PP	O
1974	1974	CD	B-NP	O
and	and	CC	I-NP	O
1982	1982	CD	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
PCI	PCI	NN	B-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
left	left	JJ	I-NP	O
main	main	JJ	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
6/18	6/18	CD	I-NP	O
and	and	CC	O	O
PTCA	PTCA	NN	B-NP	O
and	and	CC	I-NP	O
brachytherapy	brachytherapy	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
in-stent	in-stent	JJ	B-NP	O
restenosis	restenosis	NN	I-NP	O
in	in	IN	B-PP	O
April	April	NNP	B-NP	O
,	,	,	O	O
2002	2002	CD	B-NP	O
.	.	.	O	O

Intervention	Intervention	NN	B-NP	B-protein
6/18	6/18	CD	I-NP	I-protein
his	his	PRP$	B-NP	O
left	left	JJ	I-NP	O
main	main	NN	I-NP	O
was	be	VBD	B-VP	O
radiated	radiate	VBN	I-VP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
bypass	bypass	JJ	I-NP	O
vessels	vessel	NNS	I-NP	O
are	be	VBP	B-VP	O
LIMA/LAD	LIMA/LAD	NNP	B-NP	O
,	,	,	O	O
SVG/marginal	SVG/marginal	NNP	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
LIMA/LAD	LIMA/LAD	NNP	B-NP	O
,	,	,	O	O
SVG/RPDA	SVG/RPDA	NNP	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
GI	GI	NN	I-NP	O
bleed	bleed	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
aspirin	aspirin	NN	B-NP	O
and	and	CC	I-NP	O
Plavix	Plavix	NN	I-NP	O
in	in	IN	B-PP	O
2002	2002	CD	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
went	go	VBD	B-VP	O
to	to	TO	B-PP	O
17	17	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
remained	remain	VBN	I-VP	O
on	on	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
and	and	CC	I-NP	O
Plavix	Plavix	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
prostate	prostate	NN	B-NP	O
cancer	cancer	NN	I-NP	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
radiation	radiation	NN	B-NP	O
,	,	,	O	O
complicated	complicate	VBN	B-VP	O
by	by	IN	B-PP	O
radiation	radiation	NN	B-NP	O
prostatitis	prostatitis	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Diabetes	Diabete	NNS	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	VBD	B-VP	O
right	right	JJ	B-NP	O
carotid	carotid	NN	I-NP	O
endarterectomy	endarterectomy	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
TIAs	TIA	NNS	B-NP	B-protein
or	or	CC	I-NP	O
strokes	stroke	NNS	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Aspirin	Aspirin	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
;	;	:	O	O
Plavix	Plavix	NN	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
;	;	:	O	O
atenolol	atenolol	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
;	;	:	O	O
Isordil	Isordil	NN	B-NP	O
60	60	CD	B-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
;	;	:	O	O
lisinopril	lisinopril	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
;	;	:	O	O
Norvasc	Norvasc	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
;	;	:	O	O
Lipitor	Lipitor	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
;	;	:	O	O
gemfibrozil	gemfibrozil	NN	B-NP	O
600	600	CD	B-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
;	;	:	O	O
hydroxyzine	hydroxyzine	NN	B-NP	O
25	25	CD	B-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
;	;	:	O	O
Glyburide	Glyburide	NN	B-NP	O
10	10	CD	B-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
;	;	:	O	O
metformin	metformin	NN	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
000	000	CD	B-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
;	;	:	O	O
Nexium	Nexium	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
;	;	:	O	O
iron	iron	NN	B-NP	O
sulfate	sulfate	NN	I-NP	O
300	300	CD	B-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
;	;	:	O	O
calcium	calcium	NN	B-NP	O
1250	1250	CD	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
;	;	:	O	O
multivitamin	multivitamin	NN	B-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
;	;	:	O	O
vitamin	vitamin	NN	B-NP	O
E	E	NN	I-NP	O
;	;	:	O	O
folic	folic	JJ	B-NP	O
acid	acid	NN	I-NP	O
;	;	:	O	O
Colace	Colace	NNP	B-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
several	several	JJ	B-NP	O
siblings	sibling	NNS	I-NP	O
with	with	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
in	in	IN	B-PP	O
their	their	PRP$	B-NP	O
60s	60	NNS	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
He	He	PRP	B-NP	B-DNA
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
former	former	JJ	I-NP	O
engineer	engineer	NN	I-NP	O
for	for	IN	B-PP	O
Ssand	Ssand	NNP	B-NP	O
Lare	Lare	NNP	I-NP	O
,	,	,	O	O
but	but	CC	O	O
stopped	stop	VBD	B-VP	O
working	work	VBG	I-VP	O
when	when	WRB	B-ADVP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
40s	40	NNS	I-NP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
his	his	PRP$	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
any	any	DT	B-NP	O
tobacco	tobacco	NN	I-NP	O
,	,	,	O	O
alcohol	alcohol	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
drug	drug	NN	B-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
lives	live	VBZ	B-VP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
wife	wife	NN	I-NP	O
.	.	.	O	O

REVIEW	REVIEW	NNP	B-NP	O
OF	OF	IN	B-PP	O
SYSTEMS	SYSTEMS	NNP	B-NP	O
:	:	:	O	O
Two-pillow	Two-pillow	JJ	B-NP	O
orthopnea	orthopnea	NN	I-NP	O
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
stable	stable	JJ	B-ADJP	O
,	,	,	O	O
no	no	DT	B-NP	O
palpitations	palpitation	NNS	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NNP	B-NP	O
EXAMINATION	EXAMINATION	NNP	I-NP	O
:	:	:	O	O
VITAL	VITAL	JJ	B-NP	O
SIGNS	SIGNS	NN	I-NP	O
:	:	:	O	O
Temperature	Temperature	NN	B-NP	B-protein
95.1	95.1	CD	I-NP	I-protein
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
58	58	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
112/50	112/50	CD	I-NP	O
,	,	,	O	O
breathing	breathing	NN	B-NP	O
22	22	CD	I-NP	O
,	,	,	O	O
satting	satte	VBG	B-VP	O
98	98	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
Extraocular	Extraocular	JJ	B-NP	O
movements	movement	NNS	I-NP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

Pupils	Pupil	NNS	B-NP	O
equal	equal	JJ	I-NP	O
,	,	,	I-NP	O
round	round	JJ	I-NP	O
and	and	CC	I-NP	O
reactive	reactive	JJ	I-NP	O
to	to	TO	B-PP	O
light	light	NN	B-NP	O
and	and	CC	I-NP	O
accommodation	accommodation	NN	I-NP	O
.	.	.	O	O

JVP	JVP	NN	B-NP	B-protein
was	be	VBD	B-VP	O
10.0	10.0	CD	B-NP	O
cm	cm	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
carotid	carotid	NN	I-NP	O
endarterectomy	endarterectomy	NN	I-NP	O
scar	scar	NN	I-NP	O
.	.	.	O	O

CARDIOVASCULAR	CARDIOVASCULAR	NN	B-NP	O
:	:	:	O	O
Normal	Normal	JJ	B-NP	O
S1S2	S1S2	NN	I-NP	O
.	.	.	O	O

LUNGS	LUNGS	NN	B-NP	O
:	:	:	O	O
Clear	Clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

ABDOMEN	ABDOMEN	NN	B-NP	O
:	:	:	O	O
Soft	Soft	JJ	B-NP	O
,	,	,	I-NP	O
nontender	nontender	JJ	I-NP	O
,	,	,	I-NP	O
nondistended	nondistended	JJ	I-NP	O
,	,	,	I-NP	O
positive	positive	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

EXTREMITIES	EXTREMITIES	NNS	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

NEURO	NEURO	NN	B-NP	B-protein
:	:	:	O	O
Cranial	Cranial	NNP	B-NP	O
nerves	nerve	VBZ	B-VP	O
II-XII	II-XII	NN	B-NP	B-protein
intact	intact	JJ	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

Sodium	Sodium	NN	B-NP	B-protein
140	140	CD	I-NP	I-protein
,	,	,	O	O
potassium	potassium	NN	B-NP	O
5.0	5.0	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
104	104	CD	I-NP	O
,	,	,	O	O
bicarb	bicarb	NN	B-NP	O
23	23	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-DNA
35	35	CD	I-NP	I-DNA
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
1.5	1.5	CD	I-NP	O
his	his	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
is	be	VBZ	B-VP	O
1.4	1.4	CD	B-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	O
148	148	CD	I-NP	O
,	,	,	O	O
white	white	JJ	B-NP	O
count	count	NN	I-NP	O
9.0	9.0	CD	I-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
37	37	CD	I-NP	I-protein
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-cell_type
297	297	CD	B-NP	O
.	.	.	O	O

Liver	Liver	NN	B-NP	O
function	function	NN	I-NP	O
tests	test	NNS	I-NP	O
were	be	VBD	B-VP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
.	.	.	O	O

CK	CK	NN	B-NP	B-protein
125	125	CD	I-NP	I-protein
,	,	,	O	O
MB	MB	NN	B-NP	B-protein
1.6	1.6	CD	I-NP	I-protein
,	,	,	O	O
troponin	troponin	NN	B-NP	O
0.02	0.02	CD	I-NP	O
.	.	.	O	O

Electrocardiogram	Electrocardiogram	NN	B-NP	O
showed	show	VBD	B-VP	O
right	right	JJ	B-NP	O
bundle	bundle	NN	I-NP	O
branch	branch	NN	I-NP	O
block	block	NN	I-NP	O
and	and	CC	I-NP	O
2-3	2-3	NN	I-NP	O
beats	beat	NNS	I-NP	O
of	of	IN	B-PP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
interspersed	intersperse	VBN	B-VP	O
with	with	IN	B-PP	O
NSVT	NSVT	NN	B-NP	B-protein
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
Cardiovascular	Cardiovascular	NNP	I-NP	O
:	:	:	O	O
Ischemia	Ischemia	NNP	B-NP	O
:	:	:	O	O
It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
unclear	unclear	JJ	B-ADJP	O
whether	whether	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
worsening	worsen	VBG	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
was	be	VBD	B-VP	O
from	from	IN	B-PP	O
progression	progression	NN	B-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
or	or	CC	B-PP	O
whether	whether	IN	B-SBAR	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
demand	demand	NN	B-NP	O
ischemia	ischemia	NN	I-NP	O
from	from	IN	B-PP	O
his	his	PRP$	B-NP	O
frequent	frequent	JJ	I-NP	O
NSVT	NSVT	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
ruled	rule	VBN	I-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
by	by	IN	B-PP	O
enzymes	enzyme	NNS	B-NP	B-protein
but	but	CC	O	O
given	give	VBN	B-VP	O
the	the	DT	B-NP	O
persistence	persistence	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
arrhythmia	arrhythmia	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
for	for	IN	B-PP	O
catheterization	catheterization	NN	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
catheterization	catheterization	NN	I-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
LAD	LAD	NN	I-NP	O
100	100	CD	I-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
,	,	,	O	O
diag	diag	NN	B-NP	O
1	1	CD	I-NP	O
80	80	CD	I-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
circumflex	circumflex	NN	B-NP	O
100	100	CD	I-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
ramus	ramus	NN	I-NP	O
was	be	VBD	B-VP	O
widely	widely	RB	B-ADVP	O
patent	patent	NN	B-NP	O
,	,	,	O	O
RCA	RCA	NN	B-NP	B-protein
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
100	100	CD	I-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
,	,	,	O	O
right	right	JJ	B-NP	O
PDA	PDA	NN	I-NP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
.	.	.	O	O

Overall	Overall	RB	B-ADVP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
LIMA	LIMA	NNP	I-NP	O
graft	graft	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
LAD	LAD	NN	I-NP	O
was	be	VBD	B-VP	O
widely	widely	RB	B-NP	O
patent	patent	NN	I-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
SVG	SVG	NNP	I-NP	O
graft	graft	NN	I-NP	O
to	to	TO	B-PP	O
marginal	marginal	JJ	B-NP	O
1	1	CD	I-NP	O
and	and	CC	O	O
SVG	SVG	NN	B-NP	O
graft	graft	NN	I-NP	O
to	to	TO	B-PP	O
RCA	RCA	NN	B-NP	B-protein
were	be	VBD	B-VP	O
both	both	DT	O	O
occluded	occlude	VBD	B-VP	O
but	but	CC	O	O
had	have	VBD	B-VP	O
collaterals	collateral	NNS	B-NP	O
.	.	.	O	O

What	What	WP	B-NP	O
was	be	VBD	B-VP	O
new	new	JJ	B-ADJP	O
from	from	IN	B-PP	O
his	his	PRP$	B-NP	O
previous	previous	JJ	I-NP	O
catheterization	catheterization	NN	I-NP	O
was	be	VBD	B-VP	O
disease	disease	NN	B-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
PDA	PDA	NN	I-NP	B-protein
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
to	to	TO	B-VP	O
further	further	RB	I-VP	O
treat	treat	VB	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
with	with	IN	B-PP	O
medical	medical	JJ	B-NP	O
management	management	NN	I-NP	O
.	.	.	O	O

After	After	IN	B-PP	O
his	his	PRP$	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
was	be	VBD	B-VP	O
controlled	control	VBN	I-VP	O
with	with	IN	B-PP	O
amiodarone	amiodarone	NN	B-NP	O
and	and	CC	B-PP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
pacemaker	pacemaker	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
did	do	VBD	B-VP	O
however	however	RB	I-VP	O
continue	continue	VB	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
some	some	DT	B-NP	O
fatigue	fatigue	NN	I-NP	O
and	and	CC	I-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

As	As	IN	B-PP	O
a	a	DT	B-NP	O
result	result	NN	I-NP	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
adenosine	adenosine	NN	I-NP	O
MIBI	MIBI	NN	I-NP	O
to	to	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
for	for	IN	B-PP	O
functional	functional	JJ	B-NP	O
ischemia	ischemia	NN	I-NP	O
given	give	VBN	B-PP	O
the	the	DT	B-NP	O
findings	finding	NNS	I-NP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
catheterization	catheterization	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
MIBI	MIBI	NNP	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
moderate	moderate	JJ	I-NP	O
sized	sized	JJ	I-NP	O
perfusion	perfusion	NN	I-NP	O
defect	defect	NN	I-NP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
inferior	inferior	JJ	I-NP	O
and	and	CC	I-NP	O
basal	basal	JJ	I-NP	O
inferoseptal	inferoseptal	JJ	I-NP	O
and	and	CC	I-NP	O
inferolateral	inferolateral	JJ	I-NP	O
walls	wall	NNS	I-NP	O
showing	show	VBG	B-VP	O
a	a	DT	B-NP	O
moderate	moderate	JJ	I-NP	O
amount	amount	NN	I-NP	O
of	of	IN	B-PP	O
reversibility	reversibility	NN	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
was	be	VBD	B-VP	O
estimated	estimate	VBN	I-VP	O
at	at	IN	B-PP	O
50	50	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
akinesis	akinesis	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
inferior	inferior	JJ	I-NP	O
and	and	CC	I-NP	O
inferoseptal	inferoseptal	JJ	I-NP	O
walls	wall	NNS	I-NP	O
with	with	IN	B-PP	O
reduced	reduce	VBN	B-NP	O
thickening	thickening	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
any	any	DT	B-NP	O
EKG	EKG	NN	I-NP	B-protein
changes	change	VBZ	B-VP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
procedure	procedure	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
beta	beta	NN	I-NP	O
blockade	blockade	NN	I-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
to	to	TO	B-PP	O
Lopressor	Lopressor	NN	B-NP	O
50	50	CD	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
continued	continue	VBD	B-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
nitrates	nitrate	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
actually	actually	RB	B-ADJP	O
able	able	JJ	I-ADJP	O
to	to	TO	B-VP	O
tolerate	tolerate	VB	I-VP	O
ambulation	ambulation	NN	B-NP	O
without	without	IN	B-PP	O
feeling	feel	VBG	B-VP	O
any	any	DT	B-NP	O
pain	pain	NN	I-NP	O
or	or	CC	I-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
possible	possible	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
symptoms	symptom	NNS	I-NP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
later	later	RB	B-ADVP	O
on	on	IN	B-PP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
were	be	VBD	B-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
volume	volume	NN	B-NP	O
overload	overload	NN	I-NP	O
which	which	WDT	B-NP	O
responded	respond	VBD	B-VP	O
well	well	RB	B-ADVP	O
to	to	TO	B-PP	O
diuresis	diuresis	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Rafi	Rafi	NNP	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
unlikely	unlikely	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
any	any	DT	B-NP	O
intervention	intervention	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
done	do	VBN	I-VP	O
but	but	CC	O	O
he	he	PRP	B-NP	O
will	will	MD	B-VP	O
explore	explore	VB	I-VP	O
this	this	DT	B-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Pump	Pump	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
experience	experience	VB	I-VP	O
some	some	DT	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
several	several	JJ	B-NP	O
days	day	NNS	I-NP	O
into	into	IN	B-PP	O
his	his	PRP$	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
approximately	approximately	RB	B-NP	O
four	four	CD	I-NP	O
liters	liter	NNS	I-NP	O
positive	positive	JJ	B-ADJP	O
over	over	IN	B-PP	O
several	several	JJ	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
IV	IV	CD	B-NP	O
Lasix	Lasix	NNP	I-NP	O
and	and	CC	O	O
responded	respond	VBD	B-VP	O
well	well	RB	B-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
home	home	NN	B-ADVP	O
with	with	IN	B-PP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
q.	q.	NNP	I-NP	O
Monday	Monday	NNP	I-NP	O
and	and	CC	O	O
Thursday	Thursday	NNP	B-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
Rhythm	Rhythm	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
electrocardiogram	electrocardiogram	NN	I-NP	O
and	and	CC	I-NP	O
telemetry	telemetry	NN	I-NP	O
strips	strip	NNS	I-NP	O
were	be	VBD	B-VP	O
concerning	concern	VBG	I-VP	O
because	because	IN	B-SBAR	O
while	while	IN	B-SBAR	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
technically	technically	RB	B-ADVP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
usually	usually	RB	B-ADVP	O
only	only	RB	B-ADVP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
for	for	IN	B-PP	O
3-4	3-4	CD	B-NP	O
beats	beat	NNS	I-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
time	time	NN	I-NP	O
at	at	IN	B-ADVP	O
most	most	JJS	I-ADVP	O
,	,	,	O	O
and	and	CC	O	O
in	in	IN	B-PP	O
between	between	IN	B-PP	O
that	that	DT	B-NP	O
,	,	,	O	O
had	have	VBD	B-VP	O
several	several	JJ	B-NP	O
runs	run	NNS	I-NP	O
of	of	IN	B-PP	O
NSVT	NSVT	NN	B-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
NSVT	NSVT	NN	I-NP	O
never	never	RB	B-ADVP	O
progressed	progress	VBD	B-VP	O
to	to	TO	B-PP	O
sustained	sustained	JJ	B-NP	O
V-TAC	V-TAC	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
always	always	RB	B-ADVP	O
hemodynamically	hemodynamically	RB	B-ADJP	O
stable	stable	JJ	I-ADJP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
concern	concern	NN	B-NP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
could	could	MD	B-VP	O
ultimately	ultimately	RB	I-VP	O
progress	progress	VB	I-VP	O
to	to	TO	B-PP	O
ventricular	ventricular	JJ	B-NP	O
tachycardia	tachycardia	NN	I-NP	O
or	or	CC	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
loaded	load	VBN	I-VP	O
on	on	IN	B-PP	O
amiodarone	amiodarone	NN	B-NP	O
400	400	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
which	which	WDT	B-NP	O
he	he	PRP	B-NP	O
tolerated	tolerate	VBD	B-VP	O
well	well	RB	B-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
required	require	VBD	B-VP	O
an	an	DT	B-NP	O
additional	additional	JJ	I-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	B-NP	O
x	x	SYM	I-NP	O
1	1	CD	I-NP	O
load	load	NN	I-NP	O
to	to	TO	B-VP	O
stabilize	stabilize	VB	I-VP	O
his	his	PRP$	B-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
ICD	ICD	NN	I-NP	B-protein
and	and	CC	I-NP	O
DDI	DDI	NN	I-NP	O
pacemaker	pacemaker	NN	I-NP	O
placed	place	VBN	B-VP	O
on	on	IN	B-PP	O
7/26	7/26	CD	B-NP	O
without	without	IN	B-PP	O
complication	complication	NN	B-NP	O
.	.	.	O	O

After	After	IN	B-PP	O
the	the	DT	B-NP	O
pacemaker	pacemaker	NN	I-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
still	still	RB	I-VP	O
experiencing	experience	VBG	I-VP	O
some	some	DT	B-NP	O
fatigue	fatigue	NN	I-NP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
may	may	MD	B-VP	O
have	have	VB	I-VP	O
been	be	VBN	I-VP	O
overpaced	overpace	VBN	I-VP	O
.	.	.	O	O

As	As	IN	B-PP	O
a	a	DT	B-NP	O
result	result	NN	I-NP	O
his	his	PRP$	B-NP	O
settings	setting	NNS	I-NP	O
were	be	VBD	B-VP	O
adjusted	adjust	VBN	I-VP	O
to	to	TO	B-VP	O
increase	increase	VB	I-VP	O
his	his	PRP$	B-NP	O
AV	AV	NN	I-NP	O
delayed	delay	VBD	B-VP	O
240	240	CD	B-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
to	to	TO	B-PP	O
DDD	DDD	NN	B-NP	O
mode	mode	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
beats	beat	NNS	B-NP	O
shortened	shorten	VBD	B-VP	O
that	that	DT	B-NP	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
required	require	VBN	I-VP	O
to	to	TO	I-VP	O
detect	detect	VB	I-VP	O
the	the	DT	B-NP	O
VT	VT	NN	I-NP	O
,	,	,	O	O
to	to	TO	B-PP	O
24	24	CD	B-NP	O
.	.	.	O	O

By	By	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
his	his	PRP$	B-NP	O
amiodarone	amiodarone	NN	I-NP	O
was	be	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
to	to	TO	B-PP	O
400	400	CD	B-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
may	may	MD	B-VP	O
ultimately	ultimately	RB	I-VP	O
be	be	VB	I-VP	O
decreased	decrease	VBN	I-VP	O
even	even	RB	B-ADVP	O
further	further	RBR	I-ADVP	O
to	to	TO	B-PP	O
200	200	CD	B-NP	O
but	but	CC	O	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
decided	decide	VBN	I-VP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Swymer	Swymer	NNP	I-NP	O
.	.	.	O	O

4	4	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Endocrinology	Endocrinology	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
diabetes	diabete	NNS	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
held	hold	VBD	B-VP	O
his	his	PRP$	B-NP	O
metformin	metformin	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
his	his	PRP$	B-NP	O
catheterization	catheterization	NN	I-NP	O
but	but	CC	O	O
restarted	restart	VBD	B-VP	O
it	it	PRP	B-NP	O
upon	upon	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

Any	Any	DT	B-NP	O
elevated	elevated	JJ	I-NP	O
blood	blood	NN	I-NP	O
sugars	sugar	NNS	I-NP	O
were	be	VBD	B-VP	O
covered	cover	VBN	I-VP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
insulin	insulin	NN	I-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
.	.	.	O	O

5	5	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Pulmonary	Pulmonary	NNP	I-NP	O
:	:	:	O	O
As	As	IN	B-SBAR	O
mentioned	mention	VBN	B-VP	O
above	above	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
some	some	DT	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
likely	likely	RB	B-ADJP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
volume	volume	NN	B-NP	O
overload	overload	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
responded	respond	VBD	B-VP	O
well	well	RB	B-ADVP	O
to	to	TO	B-PP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	B-NP	O
Lasix	Lasix	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
always	always	RB	B-ADVP	O
maintained	maintain	VBD	B-VP	O
his	his	PRP$	B-NP	O
oxygen	oxygen	NN	I-NP	O
saturations	saturation	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
will	will	MD	B-VP	O
have	have	VB	I-VP	O
pulmonary	pulmonary	JJ	B-NP	O
function	function	NN	I-NP	O
tests	test	NNS	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
to	to	TO	B-VP	O
establish	establish	VB	I-VP	O
a	a	DT	B-NP	O
baseline	baseline	NN	I-NP	O
given	give	VBN	B-VP	O
his	his	PRP$	B-NP	O
new	new	JJ	I-NP	O
treatment	treatment	NN	I-NP	O
with	with	IN	B-PP	O
amiodarone	amiodarone	NN	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Heme	Heme	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
does	do	VBZ	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
GI	GI	NN	I-NP	O
bleed	bleed	NN	I-NP	O
on	on	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
and	and	CC	I-NP	O
Plavix	Plavix	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
monitored	monitor	VBD	B-VP	O
his	his	PRP$	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
closely	closely	RB	B-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
came	come	VBD	B-VP	O
in	in	RP	B-PRT	O
at	at	IN	B-PP	O
37	37	CD	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
did	do	VBD	B-VP	O
decrease	decrease	VB	I-VP	O
to	to	TO	B-PP	O
31	31	CD	B-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
his	his	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
bright	bright	JJ	B-NP	O
red	red	JJ	I-NP	O
blood	blood	NN	I-NP	O
per	per	IN	B-PP	O
rectum	rectum	NN	B-NP	O
.	.	.	O	O

Given	Give	VBN	B-PP	O
his	his	PRP$	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
radiation	radiation	NN	B-NP	O
proctitis	proctitis	NN	I-NP	O
and	and	CC	I-NP	O
proctatitis	proctatitis	NN	I-NP	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
not	not	RB	B-ADJP	O
surprising	surprising	JJ	I-ADJP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
this	this	DT	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
always	always	RB	B-ADVP	O
remained	remain	VBD	B-VP	O
hemodynamically	hemodynamically	RB	B-ADJP	O
stable	stable	JJ	I-ADJP	O
and	and	CC	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
require	require	VB	I-VP	O
any	any	DT	B-NP	O
transfusions	transfusion	NNS	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
baseline	baseline	NN	B-NP	O
his	his	PRP$	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
is	be	VBZ	B-VP	O
probably	probably	RB	B-ADVP	O
closer	closer	RBR	B-ADVP	O
to	to	TO	B-PP	O
33	33	CD	B-NP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
likely	likely	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
37	37	CD	I-NP	O
was	be	VBD	B-VP	O
an	an	DT	B-NP	O
elevation	elevation	NN	I-NP	O
from	from	IN	B-PP	O
decreased	decrease	VBN	B-NP	O
p.o.	p.o.	NN	I-NP	O
intake	intake	NN	I-NP	O
.	.	.	O	O

Follow	Follow	VB	B-VP	O
up	up	RP	B-PRT	O
stools	stool	NNS	B-NP	O
were	be	VBD	B-VP	O
guaiac-negative	guaiac-negative	JJ	B-ADJP	O
.	.	.	O	O

FOLLOWUP	FOLLOWUP	NN	B-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Halvorson	Halvorson	NNP	I-NP	O
and	and	CC	I-NP	O
Fabus	Fabus	NNP	I-NP	O
on	on	IN	B-PP	O
4/4/03	4/4/03	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
will	will	MD	B-VP	O
also	also	RB	I-VP	O
have	have	VB	I-VP	O
pulmonary	pulmonary	JJ	B-NP	O
function	function	NN	I-NP	O
tests	test	NNS	I-NP	O
on	on	IN	B-PP	O
5/8	5/8	CD	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Amiodarone	Amiodarone	NN	B-NP	O
400	400	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.q.d.	p.o.q.d.	NN	I-NP	O
;	;	:	O	O
aspirin	aspirin	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.q.d.	p.o.q.d.	NN	I-NP	O
;	;	:	O	O
calcium	calcium	NN	B-NP	O
carbonate	carbonate	NN	I-NP	O
1250	1250	CD	B-NP	O
p.o.	p.o.	FW	I-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
;	;	:	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
;	;	:	O	O
iron	iron	NN	B-NP	O
sulfate	sulfate	NN	I-NP	O
300	300	CD	B-NP	O
q.d.	q.d.	NN	I-NP	O
;	;	:	O	O
folate	folate	VB	B-VP	O
400	400	CD	B-NP	O
mcg	mcg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
;	;	:	O	O
gemfibrozil	gemfibrozil	NN	B-NP	O
600	600	CD	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
;	;	:	O	O
Glyburide	Glyburide	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
;	;	:	O	O
hydroxyzine	hydroxyzine	NN	B-NP	O
25	25	CD	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
;	;	:	O	O
lisinopril	lisinopril	NN	B-NP	O
20	20	CD	I-NP	O
q.d.	q.d.	NN	I-NP	O
;	;	:	O	O
Lopressor	Lopressor	NN	B-NP	O
50	50	CD	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
;	;	:	O	O
M.V.I.	M.V.I.	NNP	B-NP	O
q.d.	q.d.	NNP	I-NP	O
;	;	:	O	O
vitamin	vitamin	NN	B-NP	O
E	E	NN	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
units	unit	NNS	I-NP	O
q.d.	q.d.	RB	B-ADVP	O
;	;	:	O	O
Norvasc	Norvasc	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
;	;	:	O	O
Imdur	Imdur	NN	B-NP	O
60	60	CD	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
;	;	:	O	O
Plavix	Plavix	NN	B-NP	O
75	75	CD	I-NP	O
q.d.	q.d.	NN	I-NP	O
;	;	:	O	O
Nexium	Nexium	NN	B-NP	O
40	40	CD	I-NP	O
q.d.	q.d.	NN	I-NP	O
;	;	:	O	O
Lipitor	Lipitor	NN	B-NP	O
10	10	CD	I-NP	O
q.d.	q.d.	NN	I-NP	O
;	;	:	O	O
metformin	metformin	NN	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
000	000	CD	B-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
;	;	:	O	O
Lasix	Lasix	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
q.	q.	NN	I-NP	O
Monday	Monday	NNP	B-NP	O
and	and	CC	O	O
Thursday	Thursday	NNP	B-NP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
WESTON	WESTON	NNP	B-NP	O
G.	G.	NNP	I-NP	O
SHOLDERS	SHOLDERS	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
NR11	NR11	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
BORIS	BORIS	NNP	B-NP	O
E.	E.	NNP	I-NP	O
TAUZIN	TAUZIN	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
EQ4	EQ4	NNP	I-NP	O
AU398/407414	AU398/407414	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
95483	95483	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

QCSL746A3J	QCSL746A3J	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
1/1/03	1/1/03	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
1/1/03	1/1/03	CD	B-NP	O

